Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen
- PMID: 1531958
Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen
Abstract
Natural suppressor (NS) activity has been identified in several sites of active hematopoiesis. In this study we characterized NS activity in murine bone marrow (BM) using monoclonal antibodies (mAbs) to interleukin 3 (IL-3) receptor-associated antigen (IL-3RAA) and various cytokines that exert a strong influence on hematopoiesis or lymphocyte interaction. NS activity of BM cells of relatively low density was enhanced by IL-3 or granulocyte-macrophage colony-stimulating factor (GM-CSF). When the BM cells were separated into IL-3RAA+ cells and IL-3RAA- cells, the IL-3RAA+ cells demonstrated potent NS activity, whereas IL-3RAA- cells had either no or weak NS activity. The IL-3RAA+ cells showed non-T- and non-B-cell phenotype and had high affinity to wheat germ agglutinin (WGA), a marker for hematopoietic progenitors. In assays for hematopoietic activity, it appeared that the early differentiating progenitors (day 8 spleen colony-forming units [CFU-S], granulocyte-macrophage colony-forming units [CFU-GM]) were enriched in the IL-3RAA+ cell population, whereas more immature multipotent progenitors (day 12 CFU-S, granulocyte erythrocyte macrophage megakaryocyte colony-forming units [CFU-GEMM]) were contained in the IL-3RAA- cell population. Both suppressor cells and IL-3RAA+ cells spontaneously developed from the IL-3RAA- cell population. These findings suggest that NS cells in murine BM are early hematopoietic progenitors and are probably committed to the myeloid lineage. Hybridoma cells established between the IL-3RAA+ cells and BW5147 cells produced suppressor factor(s). This finding suggests that the NS cells produce soluble mediator(s) that may be responsible for their suppressive action.
Similar articles
-
Bone marrow natural suppressor cells inhibit the growth of myeloid progenitor cells and the synthesis of colony-stimulating factors.Exp Hematol. 1992 Nov;20(10):1178-83. Exp Hematol. 1992. PMID: 1426097
-
Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.Exp Hematol. 1992 Feb;20(2):201-8. Exp Hematol. 1992. PMID: 1371965
-
Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.Exp Hematol. 1995 Apr;23(4):335-40. Exp Hematol. 1995. PMID: 7895781 Clinical Trial.
-
Role of the interleukin 5 receptor system in hematopoiesis: molecular basis for overlapping function of cytokines.Bioessays. 1992 Aug;14(8):527-33. doi: 10.1002/bies.950140806. Bioessays. 1992. PMID: 1365906 Review.
-
Antibodies against pluripotent stem cells: their use in studying stem cell function.Blood Cells. 1979 Jun 15;5(2):175-91. Blood Cells. 1979. PMID: 400286 Review.
Cited by
-
Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence.Cancer Immunol Immunother. 1995 Jul;41(1):37-45. doi: 10.1007/BF01788958. Cancer Immunol Immunother. 1995. PMID: 7641218 Free PMC article.
-
The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.J Clin Invest. 1997 Mar 1;99(5):1118-29. doi: 10.1172/JCI119240. J Clin Invest. 1997. PMID: 9062371 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous